Male mammary gland development after apatinib therapy in advanced gastric cancer: A case report

RATIONALE: Most gastric cancer patients are diagnosed at mid- to late-stage and lose the chance of radical surgery, medical treatment is especially important to prolong the survival of patients. Apatinib mesylate, which is a small molecule vascular endothelial growth factor receptor 2 tyrosine kinas...

Descripción completa

Detalles Bibliográficos
Autores principales: Hui, Yan, Wang, Jingchun, Han, Jianguo, Guo, Zhifeng, Sun, Siqi, Wu, Zifang, Wang, Yanqiu, Han, Zhimin, Chen, Xiangbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360214/
https://www.ncbi.nlm.nih.gov/pubmed/32664067
http://dx.doi.org/10.1097/MD.0000000000020727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360214/
https://www.ncbi.nlm.nih.gov/pubmed/32664067
http://dx.doi.org/10.1097/MD.0000000000020727

Ejemplares similares